General discussion, page-11566

First 11566 Last

Share
Profile

Follow
Greenwave17

931 Posts.

566

24/01/22

22:46

Post #: 59101768
Share

Originally posted by thevinnys: ↑

Regarding OSA - Surely I am not the only one that can see an alignment/pivot based on foundations of success?

Action A. Open-Label Extension Study - Not required if negative results
Action B. Using Data from Alfred Trial to support the International Patent Application - Not required if Negative Results
Action C. Additional Study at UWA - Not required if Negative Results
Action D. Dual Locations studies for further evidence to advance FDA approval - Not required if Negative Results
Action E. Preparation of PRE-IND FDA meeting package with aim of a meeting with FDA for Q1, 2022. - Not Required if Negative Results
Action F Listing on the NASDAQ to coincide with the release of results from our IHL-42X - Not required to coincide, NASDAQ Listing, if Negative
Action G Appoint New York Based PR firm to represent/arrange for Medical Conferences - Not Required if Negative Results
Action H Setup USA Office strategic stakeholder engagement with clinical research facilitators, regulatory authorities, and the investment
community - Not Required if Negative Results.
Action I CEO move to USA to set up our US office and networks - Not Required if Negative Results
Price fluctuations will always be here.

Just need patience for the prices to re-align with the business

GLAH

Expand

Great post mate....Agree 100% !!! It makes perfect sense. They know what they are sitting on and are setting the stage for the successful launch of OSA results to the market. Ignore other posters that compare themselves to Batman or Al Pacino in Scarface...LOL...I see no value in their posts at all, IMO !!!

IHL-42X is the launch pad that will put this company into the spotlight.....similar to what a certain movie role can do for an actors career !!!

IHL Price at posting: 48.0¢ Sentiment: Buy Disclosure: Held
10 Upvote

0 Great analysis

Reply

Top Stories

Tonight's US CPI data could set the tone for November. What are markets expecting?

ARB

Court process clears way for ARB to buy up 4 Wheel Parts business in the US

OCT

Octava Minerals joins the antimony train with high-grades on the radar at Yallagong, WA

IMA

Issues emerging as Australian companies tackle critical minerals challenge

ARV

Smallcap Artemis Res' jumps 23% on six digit gold grade rockchip find at Titan